Manama, Dr. Ahmed Mohammed Al Ansari, Chief Executive of the National Health Regulatory Authority (NHRA), and Dr. Hisham Saad Al Jadhey, CEO of Saudi Food and Drug Authority (SFDA), signed a Memorandum of Understanding (MoU) to enhance collaboration on the approval of pharmaceuticals and medical devices between Bahrain and Saudi Arabia. The signing was attended by Lieutenant General Dr. Shaikh Mohamed bin Abdullah Al Khalifa, Chairman of the Supreme Council of Health (SCH). Dr. Al Ansari affirmed that this agreement strengthens cooperation between the two authorities, enabling Bahrain to recognise and approve pharmaceutical products and medical devices already authorised by Saudi Arabia's SFDA. He added that the MoU will allow for smoother regulatory processes by aligning standards for pharmaceuticals and medical devices approved by the SFDA, supporting the health sector in both countries. The NHRA and SFDA have signed an agreement in 2019. Source: Bahrain News Agency
Related Articles
On the pretext of entering Jerusalem illegally – the forces arrest a number of young men
The occupation forces arrested a number of young men holding West Bank ID cards.
Eyewitnesses said that the forces stopped a vehicle in the town of Beit Hanina, north of Jerusalem, checked the passengers’ IDs, and then arrested them on the pretext of…
Security update: Israeli artillery targets multiple southern Lebanese towns
Several southern Lebanese towns have been subjected to Israeli enemy artillery shelling, our reporter said on Thursday.
The town of Khiyam came under fire, followed by the outskirts of Marwahin in the western sector.
Around 2:30 pm, the town of Yar…
Wall Street drifts, and crude oil slides ahead of a frenetic week
New York, stock indexes are drifting in mixed trading Monday ahead of a week full of earnings reports from Wall Street’s most influential companies and a Federal Reserve meeting on interest rates.
The SandP 500 was 0.2% higher in late trading, coming…